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Background: Apathy and depression are important neuropsychiatric disorders that can occur after a stroke but the
etiology and risk factors are not well understood. The purpose of this study was to identify risk factors for apathy
and depression following a stroke.
Methods: Patients with an acute stroke who met the inclusion criteria were recruited from our hospital, and general
information was recorded from patient charts. The Apathy Evaluation Scale, Clinician Version (AES-C) was used to
evaluate these patients within 2 weeks after the stroke. The Montreal Cognitive Assessment (MoCA), mini-mental state
examination (MMSE), Hamilton Depression Scale (HAMD), Mattis Dementia Rating Scale Initiation/Perseveration subset
(MDRS I/P), Frontal Assessment Battery (FAB) and Stroop Color-Word Association Test were employed to evaluate
emotion, cognitive function and executive function. The patients were divided into two groups: the apathy group and
the non-apathy group. We also divided the patients into two groups based on whether or not they had post-stroke
depression. The clinical characteristics and scores on the MoCA, MMSE, HAMD and MDRS I/P were compared between
the apathy and non-apathy groups as well as between patients with and without depression. Logistic regression
analysis was performed to identify risk factors for apathy and depression following a stroke.
Results: A total of 75 patients with acute stroke were recruited. Of these, 25 (33.3%) developed apathy and 12 (16%)
developed depression. Multivariate logistic regression analysis indicated that a history of cerebrovascular disease
(OR: 6.45, 95% CI: 1.48-28.05, P = 0.013), low HbA1c (OR: 0.31, 95% CI: 0.12-0.81, P = 0.017) and a low MDRS I/P score
(OR: 0.84, 95% CI: 0.74, 0.96, P = 0.010) were risk factors for post-stroke apathy. Additionally, multivariate logistic regression
indicated that a low MDRS I/P (OR: 0.85, 95% CI: 0.75, 0.97, P = 0.015) was associated with post-stroke depression.
Conclusions: Three risk factors for post-stroke apathy were identified as a history of cerebrovascular disease, low HbA1c
and lower MDRS I/P scores. A low MDRS I/P score was also identified as a risk factor for post-stroke depression. These
results may be useful to clinicians in recognizing and treating apathy and depression in patients after a stroke.
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Apathy and depression are important neuropsychiatric
symptoms that can occur after a stroke and may be the
core symptoms in some stroke patients [1,2]. It has been
reported that in the acute phase of a stroke, 15.2-71% of
patients demonstrate apathy [3]. Three to six months
after a stroke the incidence of apathy has been reported
to be 26.7% versus 5.4% in controls [4].
Cognitive dysfunction has been found to be related to
apathy [5,6]; however, some patients with moderate to* Correspondence: solovita.yang@gmail.com
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reproduction in any medium, provided the orsevere dementia do not show apathy so cognitive dys-
function per se does not produce apathy [7]. Some pa-
tients with post-stroke depression develop apathy [5];
however, apathy should probably be regarded as different
from depression and it requires distinct prognostic and
therapeutic strategies. For example, it has been found
that in patients with a stroke, crying and sadness were
associated with a subjective feeling of depression
whereas apathy was not [8]. The situation may be more
complex, however, as a relationship between depression
and apathy could develop over time. A recent study
found that 3 months after a stroke there was no signifi-
cant overlap between apathy and depression, but one
year later there was a significant overlap [9]. One groupd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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depression and apathy proposed that “post-stroke de-
pression” is really comprised of two syndromes, affective
or depressive post-stroke depression and apathetic post-
stroke depression, and that they have different neuroana-
tomical mechanisms [10].
It is important to identify stroke patients who are
apathetic and to make the distinction between apathy
and depression for several reasons: apathy increases the
burden on caregivers, apathetic patients have been found
to require longer hospitalizations and patients with ap-
athy tend to participate less in rehabilitation [4]. Apathy
and depression are also treated differently.
Knowledge about the risk factors for post-stroke ap-
athy and depression would make it less likely that a clin-
ician would fail to recognize and treat them. The aim of
this study was to explore the risk factors for post-stroke
apathy and depression in the subacute stage of a stroke.
Methods
This study was approved by the Institutional Review
Board of Guangzhou First Municipal People’s Hospital
(No. 024, 2010). Informed consent was obtained from all
patients before the study. The scale assessments were
done by a qualified psychiatric specialist and the testing
was confirmed by a psychiatrist and a neurologist.
Patients
We reviewed the charts of 270 patients hospitalized for
an acute stroke between December 2010 and December
2011. After detail evaluation with inclusion and exclu-
sion criteria, 75 patients were used for this study. Inclu-
sion criteria were: patients with a diagnosis of ischemic
stroke (IS) according to valid ICD-10 codes [11], the
stroke had occurred within the previous 7 days, comput-
erized tomography (CT) was performed to exclude cere-
bral hemorrhage, patients were conscious and their
Glasgow Coma Scale (GCS) scores were 15, patients
were able to cooperate with the testing, and their admis-
sion NIH Stroke Scale (NIHSS) score was ≤8. All pa-
tients had acute lacunar infarctions.
Exclusion criteria were: patients with a diagnosis or
history of atrial fibrillation, those with a history of
schizophrenia, depression, anxiety or other mental ill-
ness, including dementia, Parkinson’s disease and other
neurodegenerative diseases, the development of symp-
toms of severe aphasia so that patients were unable to
complete the evaluation, severe heart, liver or kidney
dysfunction, malignancies or thyroid diseases, contrain-
dications to magnetic resonance imaging (MRI) such as
pacemaker implantation and claustrophobia, drug abuse
or drug dependence, and refusal to participate in the
study. Smoking was defined as: Non-smoker, Ex-smoker
who used to smoke but had quit, Current smoker wasdefined as those who continued to smoke 1–19 ciga-
rettes per day during the study period [12]. Drinking
was defined as: (1) Non-drinker who did not have a his-
tory of drinking in the past or was an occasional drinker
(< 1 drink, where 1 unit equals to 8 gram of alcohol per
week), (2) Light drinker of 1–15 units per week, (3)
Moderate drinker of 16–42 units per week, (4) Heavy
drinker of > 42 units per week, (5) Ex-drinker who used
to drink but had quit [13].
Collection of general information and grouping
Patients who met the inclusion criteria were recruited
and their clinical information was recorded in detail.
Data were recorded on hypertension, diabetes, a history
of cerebral vascular disease and other chronic diseases.
The NIHSS score had been recorded on admission. The
evaluation of apathy was carried out using the Apathy
Evaluation Scale, clinician version (AES-C) within
2 weeks after onset of the stroke. The AES was devel-
oped by Marin et al. and its reliability has been shown
to be satisfactory [14]. The diagnostic criteria for apathy
in this study were based on the Marin scale [14] and
Robert et al. [15]. These criteria were (1) a lack of motiv-
ation relative to the patient’s previous level of function-
ing or the standards of his/her age and culture, (2) the
presence of at least one symptom from the following
three domains: (i) diminished goal-directed behavior
(lack of effort, dependency on others to structure activ-
ity); (ii) diminished goal-directed cognition (lack of
interest or concern about one’s personal problems), or
(iii) diminished concomitant to goal-directed behavior
(unchanging affect, lack of emotional responsiveness),
(3) the symptoms cause clinically significant distress or
impairment in social and occupational functioning, and
(4) the absence of a diminished level of consciousness or
administration of substances such as narcotics or medi-
cations [15].
Detection of emotion, cognitive function and executive
function
Within 2 weeks after the stroke, the Montreal Cognitive
Assessment (MoCA), mini-mental state examination
(MMSE), Hamilton Depression Scale (HAMD), Mattis
Dementia Rating Scale initiation/perseverance subscale
(MDRS I/P), Frontal Assessment Battery (FAB) and
Stroop Color Word Test were employed to evaluate
emotion, cognitive function and executive function. The
MDRS can be used to evaluate attention, initiation/per-
severation (I/P), construction, conceptualization and
memory. The reliability of the MDRS Chinese version
has been validated [16]. The MDRS I/P is one part of
the MDRS and includes language production and coher-
ent motion, and is used to assess the ability to initiate
and sustain motion, as these are closely related to
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Word Test, two cards were used for testing. Card A was
the Stroop color card and Card B the color word card.
The time to complete the evaluation with each card was
recorded and the difference between them was calculated
(B-Atime). The number of correct answers was recorded
for each card and the difference was calculated
(B-Anumber). On the HAMD, >35 points was considered to
be an indication of serious depression and >20 points as
mild or moderate depression. A MoCA score of <25
but ≥14 was defined as mild cognitive impairment (MCI).
The scale assessments for the FAB were performed by a
qualified psychiatric specialist and the testing was con-
firmed by a psychologist and a neurologist.
According to the Diagnostic and Statistical Manual of
Mental Disorders (DSM IV), the criteria for major depres-
sion area depressed state of mind for most of the day, and
at least four of the following: (1) loss of interest in or no
pleasant feelings about activities, (2) the loss of energy or
fatigue, (3) psychomotor retardation or agitation, (4) feel-
ings of worthlessness, (5) diminished ability to think or
concentrate, (6) recurrent thoughts of death, (7) sleep dis-
orders such as insomnia or sleeping too much, and (8) sig-
nificant weight loss or weight gain. The criteria for
severity include impaired social functioning and pain or
adverse consequences for the depressed individual. The
symptom criteria and the severity criteria must have lasted
for at least 2 weeks. The symptoms cannot be due to sub-
stances or a general medical condition.
According to the findings on T2-weighted images, the
infarct lesions were located in the bilateral frontal lobes,
temporal lobes, parietal lobe, occipital lobe, basal gan-
glia, corona radiata or brain stem.
The AES-C consists of 18 items which provide an index
of overt goal-directed behavior, goal-related cognitions,
and goal-related emotional responses. Factor analysis
using principal component analysis was performed. The
Kaiser-Meyer-Olkin (KMO) score for the AES-C was 0.84,
indicating sampling adequacy (≥.50). Bartlett’s test of
sphericity was statistically significant. The overall
Cronbach’s alpha for internal consistency of the 18-item
instrument was 0.87. HbA1c shows the average level of
blood glucose over the previous three months and < 5.6%
is considered normal.
Statistical analysis
Comparison between the patients with and without
post-stroke apathy and between those with and without
post-stroke depression was conducted using the inde-
pendent two-sample t test for continuous variables. The
chi-square/Fisher’s exact test was used for categorical
variables; the data are presented as numbers (percent-
ages). Because multiple measurements were employed to
evaluate emotion, cognitive function and executivefunction, Bonferroni corrections were used to reduce the
chance of obtaining false-positive results. Univariate lo-
gistic regression analysis was performed to analyze the
odds ratios of significant factors associated with patients
with post-stroke apathy and post-stroke depression. Var-
iables having a p value <0.2 in the univariate analysis
were selected and evaluated by multivariate logistic re-
gression models with the conditional forward selection
method. All statistical assessments were two-tailed and
p < 0.05 was considered statistically significant. Statistical
analyses were performed using SPSS 15.0 statistical soft-
ware (SPSS Inc, Chicago, IL).
Results
Twenty-five (33.3%) of the 75 enrolled patients (28 women
and 47 men) were diagnosed as having post-stroke apathy.
The mean age of these patients was 66.7 ± 9.3 years (range,
48 to 84 years). Table 1 summarizes the demographic and
clinical characteristics of the 25 patients with post-stroke
apathy and the 50 patients without post-stroke apathy.
There were significant differences between the two groups
in age, education, frontal lesion location and HbA1c levels
(p < 0.05). Twelve of the 75 patients (16%) had post-stroke
depression. Table 2 summarizes the demographic and clin-
ical characteristics of the patients with and without post-
stroke depression. There was a significant difference be-
tween the two groups if the lesion was located in the tem-
poral lobe (p = 0.048).
Table 3 shows the assessments of cognition and depres-
sion for the patients with and without post-stroke apathy.
There were significant differences in MMSE, MoCA, and
MDRS I/P scores between the two groups (p < 0.01). Pa-
tients without post-stroke apathy had significantly higher
scores on the MMSE, MoCA, and MDRS I/P than did pa-
tients with post-stroke apathy. Assessments of cognition
for patients with and without post-stroke depression are
shown in Table 4. There was a significant difference in
MDRS I/P scores between the two groups (p = 0.009).
Patients without post-stroke depression had a signifi-
cantly higher score on the MDRS I/P than did patients
with post-stroke depression.
Table 5 presents the results of univariate and multivari-
ate analysis to determine the factors potentially associated
with post-stroke apathy. The univariate logistic regression
model indicated that the following factors were signifi-
cantly associated with post-stroke apathy: age, education,
frontal lesion location, HbA1c, MMSE, MoCA and MDRS
I/P (P < 0.05). Multivariate logistic regression indicated
that a history of cerebrovascular disease (OR: 6.45, 95%
CI: 1.48-28.05, P = 0.013), low HbA1c (OR: 0.31, 95% CI:
0.12-0.81, P = 0.017) and low MDRS I/P scores (OR: 0.84,
95% CI: 0.74, 0.96, P = 0.010) were associated with post-
stroke apathy. In addition, the results of multivariate logis-
tic regression indicated that a low MDRS I/P (OR: 0.85,
Table 1 Comparison of demographics, anthropometric
characteristics, and hormonal and metabolic features






(n = 25) (n = 50)
Age (yrs)1 70.7 ± 9.0 64.7 ± 8.9 0.007*
Gender, n (%)2
Male 15 (60.0) 32 (64.0) 0.736
Female 10 (40.0) 18 (36.0)
Education (yrs) 6.3 ± 5.3 9.0 ± 4.0 0.017*
Lesion location, n (%)2
Frontal 12 (40.0) 10 (20.0) 0.012*
Temporal 6 (24.0) 4 (8.0) 0.075
Parietal 1 (4.0) 5 (10.0) 0.657
Occipital 1 (4.0) 4 (8.0) 0.659
Basal ganglia 18 (72.0) 35 (70.0) 0.858
Cerebellum 1 (4.0) 4 (8.0) 0.659
Brain stem 11 (44.0) 16 (32.0) 0.307
Corona radiata 6 (24.0) 4 (8.0) 0.075
Medical history, n (%)2
Cerebrovascular disease 12 (48.0) 13 (26.0) 0.057
Hypertension 14 (56.0) 35 (70.0) 0.230
Diabetes mellitus 4 (16.0) 13 (26.0) 0.330
Smoking, n (%)2 0.703
Non-smoker 12 (48.0) 27 (56.0)
Ex-smoker 3 (12.0) 3 (4.0)
Current smoker 10 (40.0) 20 (40.0)
Drinking, n (%)2 0.341
Non-drinker 17 (68.0) 38 (76.0)
Light drinker 4 (16.0) 2 (4.0)
Moderate drinker 3 (12.0) 8 (16.0)
Heavy drinker 0 (0.0) 0 (0.0)
Ex-drinker 1 (4.0) 2 (4.0)
SBP (mmHg)1 148.7 ± 19.5 155.0 ± 21.1 0.215
DBP (mmHg)1 78.9 ± 12.8 86.8 ± 18.2 0.055
Heart rate (bpm)1 72.9 ± 12.7 74.4 ± 11.6 0.616
Total cholesterol (mmol/L)1 4.7 ± 0.9 5.0 ± 0.9 0.227
Triglycerides (mmol/L)1 1.4 ± 0.6 1.9 ± 1.3 0.081
LDL-C (mmol/L)1 2.7 ± 0.6 2.9 ± 0.7 0.340
HDL-C (mmol/L)1 1.1 ± 0.3 1.1 ± 0.3 0.578
HbA1c (%)1 5.8 ± 0.9 6.8 ± 1.7 0.018*
NIHSS1 2.4 ± 2.3 2.2 ± 2.3 0.612
*Indicates a significant difference between patients with and without
post-stroke apathy, p < 0.05.
p values are from 1independent two sample tests and 2chi-square/Fisher’s
exact tests.
Data are displayed as mean ± standard deviation and number (percentage).
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL-C
Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein
cholesterol, HbA1c Hemoglobin A1c, NIHSS National institutes of health
stroke scale.
Table 2 Comparison of demographics, anthropometric
characteristics, and hormonal and metabolic features






(n = 12) (n = 63)
Age (yrs)1 66.0 ± 11.5 66.8 ± 8.9 0.780
Gender, n (%)2 0.346
Male 6 (50.0) 41 (65.1)
Female 6 (50.0) 22 (34.9)
Education (yrs) 9.6 ± 4.6 7.8 ± 4.5 0.223
Lesion location, n (%)2
Frontal 3 (25.0) 19 (30.2) 1.000
Temporal 4 (33.3) 6 (9.5) 0.048*
Parietal 1 (8.3) 5 (7.9) 1.000
Occipital 2 (16.7) 3 (4.8) 0.179
Basal ganglia 10 (83.3) 43 (68.3) 0.491
Cerebellum 2 (16.7) 3 (4.8) 0.179
Brain stem 3 (25.0) 24 (38.1) 0.519
Corona radiata 9 (75.0) 43 (68.3) 0.745
Medical history, n (%)2
Cerebrovascular disease 6 (50.0) 19 (30.2) 0.198
Hypertension 1 (8.3) 16 (25.4) 0.277
Diabetes mellitus 8 (66.7) 41 (65.1) 1.000
Smoking, n (%)2 0.893
Non-smoker 7 (58.3) 32 (50.8)
Ex-smoker 1 (8.3) 5 (7.9)
Current smoker 4 (33.4) 26 (41.3)
Drinking, n (%)2 1 (8.3) 19 (30.2) 0.177
Non-drinker 10 (91.7) 44 (69.8)
Light drinker 0 (0.0) 6 (9.5)
Moderate drinker 0 (0.0) 11 (17.5)
Heavy drinker 0 (0.0) 0 (0.0)
Ex-drinker 1 (8.3) 2 (3.2)
SBP (mmHg)1 148.8 ± 24.0 153.7 ± 20.1 0.454
DBP (mmHg)1 84.2 ± 16.2 84.1 ± 17.1 0.982
Heart rate (bpm)1 75.3 ± 12.7 73.7 ± 11.8 0.659
Total cholesterol
(mmol/L)1
5.1 ± 1.0 4.8 ± 0.9 0.391
Triglycerides (mmol/L)1 1.6 ± 0.7 1.8 ± 1.2 0.662
LDL-C (mmol/L)1 3.0 ± 0.7 2.8 ± 0.7 0.383
HDL-C (mmol/L)1 1.2 ± 0.3 1.1 ± 0.3 0.488
HbA1c (%)1 6.1 ± 1.4 6.5 ± 1.6 0.449
NIHSS1 2.6 ± 2.7 2.2 ± 2.2 0.548
*Indicates a significant difference between patients with and without
post-stroke depression, p < 0.05.
p values are from 1independent two sample tests and 2 chi-square/Fisher’s
exact tests.
Data are displayed as mean ± standard deviation and number (percentage).
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL-C
Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol,
HbA1c Hemoglobin A1c, NIHSS National Institutes of health stroke scale.
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Table 3 Comparison of assessments of cognition and







(n = 25) (n = 50)
MMSE score 23.0 ± 4.9 26.7 ± 2.8 <0.001*
MoCA score 17.3 ± 5.4 21.6 ± 4.9 0.001*
MDRS I/P 27.2 ± 5.1 31.7 ± 5.0 0.001*
FAB 12.3 ± 3.8 13.9 ± 2.9 0.050
HAMD 6.2 ± 5.3 4.2 ± 3.2 0.046*
Stroop color-naming
B-Atime 73.3 ± 47.9 59.3 ± 43.3 0.208
B-Anumber −6.6 ± 8.2 −3.3 ± 6.9 0.070
* Indicates a significant difference between patients with and without
post-stroke apathy, p < 0.01.
p values are from independent two sample tests and data are displayed as
mean ± standard deviation.
Bonferroni corrections were used to reduce the chance of obtaining
false-positive results.
Abbreviations: MMSE Mini-mental state examination, MoCA Montreal cognitive
assessment, MDRS I/P Mattis dementia rating scale initiation/preservation
subset, FAB Frontal assessment battery, HAMD Hamilton depression scale.
Table 5 Determinants of significant risk factors
associated with post-stroke apathy (n = 75)
Univariate Multivariate
OR (95% CI) p-value OR (95% CI) p-value
Age (yrs) 1.08 (1.02, 1.15) 0.011*
Gender
Female vs. Male 1.19 (0.44, 3.18) 0.736
Education (yrs) 0.87 (0.77, 0.98) 0.021*
Frontal
Yes vs. no 3.69 (1.30, 10.52) 0.014*
Temporal
Yes vs. no 3.63 (0.92, 14.34) 0.066
Parietal
Yes vs. no 0.38 (0.04, 3.40) 0.383
Occipital
Yes vs. no 0.48 (0.05, 4.53) 0.521
Basal ganglia
Yes vs. no 1.10 (0.38, 3.18) 0.858
Cerebellum
Yes vs. no 0.48 (0.05, 4.53) 0.521
Brain stem
Yes vs. no 1.67 (0.62, 4.49) 0.309
Corona radiata
Yes vs. no 1.63 (0.55, 4.84) 0.378
Cerebrovascular disease
Yes vs. no 2.63 (0.96, 7.20) 0.060 6.45 (1.48, 28.05) 0.013*
Hypertension
Yes vs. no 0.55 (0.20, 1.48) 0.232
Diabetes mellitus
Yes vs. no 0.54 (0.16, 1.88) 0.334
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post-stroke depression (Table 6). Table 7 presents the re-
sult of univariate multinomial logistic regression using pa-
tients without apathy and depression (n = 44) as the
reference category. Table 7 had shown an increased risk of
patients without apathy and with depression for temporal
(OR = 10.50, 95% CI: 1.15–95.91), cerebellum (OR = 10.50,
95% CI: 1.15–95.91) and higher HAMD (OR = 8.01, 95%
CI: 1.27–50.73). Risk of patients with apathy and withoutTable 4 Comparison of assessments of cognition between






(n = 12) (n = 63)
MMSE score 24.6 ± 4.3 25.6 ± 4.0 0.426
MoCA score 18.0 ± 5.2 20.6 ± 5.4 0.125
MDRS I/P 26.5 ± 5.7 30.9 ± 5.1 0.009*
FAB 13.3 ± 3.3 13.4 ± 3.3 0.976
Stroop color-naming
B-Atime 73.8 ± 59.6 62.1 ± 42.0 0.412
B-Anumber −5.8 ± 9.9 −4.1 ± 6.9 0.458
* Indicates a significant difference between patients with and without
post-stroke apathy, p < 0.01.
p values are from independent two sample tests and data are displayed as
mean ± standard deviation.
Bonferroni corrections were used to reduce the chance of obtaining
false-positive results.
Abbreviations: MMSE Mini-mental state examination, MoCA Montreal cognitive
assessment, MDRS I/P Mattis dementia rating scale initiation/preservation
subset, FAB Frontal assessment battery.
Smoking
Yes vs. no 1.27 (0.49, 3.33) 0.624
Drinking
Yes vs. no 1.49 (0.52, 4.31) 0.462
SBP (mmHg) 0.99 (0.96, 1.01) 0.214
DBP (mmHg) 0.96 (0.93, 1.00) 0.059
Heart rate (bpm) 0.99 (0.95, 1.03) 0.610
Total cholesterol (mmol/L) 0.71 (0.40, 1.24) 0.226
Triglycerides (mmol/L) 0.49 (0.22, 1.07) 0.074
LDL-C (mmol/L) 0.69 (0.32, 1.48) 0.335
HDL-C (mmol/L) 0.61 (0.11, 3.39) 0.572
HbA1c (%) 0.44 (0.20, 0.97) 0.043* 0.31 (0.12, 0.81) 0.017*
NIHSS 1.06 (0.86, 1.30) 0.606
MMSE score 0.77 (0.66, 0.90) 0.001*
MoCA score 0.85 (0.77, 0.95) 0.003*
MDRS I/P 0.85 (0.76, 0.94) 0.001* 0.84 (0.74, 0.96) 0.010*
FAB 0.87 (0.75, 1.00) 0.057
HAMD 1.13 (1.00, 1.27) 0.059
Table 5 Determinants of significant risk factors
associated with post-stroke apathy (n = 75) (Continued)
Stroop color-naming
B-Atime 1.01 (1.00, 1.02) 0.211
B-Anumber 0.94 (0.88, 1.01) 0.087
*Significance factor, p < 0.05.
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL-C
Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein
cholesterol, HbA1c Hemoglobin A1c, NIHSS National Institutes of health stroke
scale, MMSE Mini-mental state examination, MoCA Montreal cognitive
assessment, MDRS I/P Mattis dementia rating scale initiation/preservation
subset, FAB Frontal assessment battery, HAMD Hamilton depression scale.
Table 6 Determinants of significant risk factors
associated with post-stroke depression (n = 75)
Univariate Multivariate
OR (95% CI) p-value OR (95% CI) p-value
Age (yrs) 0.99 (0.93, 1.06) 0.777
Gender
Female vs. Male 1.86 (0.54, 6.47) 0.327
Education (yrs) 1.09 (0.95, 1.26) 0.223
Frontal
Yes vs. no 0.77 (0.19, 3.17) 0.720
Temporal
Yes vs. no 4.75 (1.10, 20.57) 0.037*
Parietal
Yes vs. no 1.06 (0.11, 9.92) 0.963
Occipital
Yes vs. no 4.00 (0.59, 27.02) 0.155
Basal ganglia
Yes vs. no 2.33 (0.67, 11.61) 0.304
Cerebellum
Yes vs. no 4.00 (0.59, 27.02) 0.155
Brain stem
Yes vs. no 0.54 (0.13, 2.20) 0.391
Corona radiata
Yes vs. no 1.39 (0.34, 5.72) 0.643
Cerebrovascular disease
Yes vs. no 2.36 (0.66, 8.11) 0.189
Hypertension
Yes vs. no 1.07 (0.29, 3.97) 0.916
Diabetes mellitus
Yes vs. no 0.27 (0.03, 2.23) 0.223
Smoking
Yes vs. no 0.47 (0.21, 2.57) 0.633
Drinking
Yes vs. no 0.21 (0.03, 1.75) 0.149
SBP (mmHg) 0.99 (0.96, 1.02) 0.449
DBP (mmHg) 1.00 (0.96, 1.04) 0.982
Heart rate (bpm) 1.01 (0.96, 1.07) 0.654
Total cholesterol (mmol/L) 1.36 (0.68, 2.71) 0.386
Triglycerides (mmol/L) 0.86 (0.44, 1.68) 0.658
LDL-C (mmol/L) 1.52 (0.60, 3.82) 0.378
HDL-C (mmol/L) 2.06 (0.27, 15.48) 0.483
HbA1c (%) 0.82 (0.49, 1.37) 0.450
NIHSS 1.09 (0.83, 1.42) 0.543
MMSE score 0.94 (0.82, 1.09) 0.425
MoCA score 0.92 (0.82, 1.03) 0.130
MDRS I/P 0.85 (0.75, 0.97) 0.015* 0.85 (0.75, 0.97) 0.015*
FAB 0.99 (0.82, 1.21) 0.975
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1.04–121), less education (OR = 0.73, 95% CI: 0.61–0.88),
frontal (OR = 6.19, 95%CI: 1.88–20.34), brain stem (OR =
3.28, 95% CI: 1.07–10.02), lower MMSE score (OR = 0.72,
95%CI: 0.59–0.87), lower MoCA score (OR = 0.82, 95%CI:
0.73–0.0.93), lower MDRS I/P (OR = 0.85, 95%CI: 0.75–
0.95), lower MDRS I/P (OR = 0.85, 95%CI: 0.75–0.95), and
lower FAB (OR = 0.81, 95%CI: 0.69–0.96). The results of
multivariate multinomial logistic regression were not es-
timable because of small sample size.
Discussion
Risk factors for post-stroke apathy and depression
In this study, we compared 25 stroke patients who had
apathy with 50 stroke patients who did not. The two
groups were similar except that the apathy group was
significantly older, had significantly fewer years of educa-
tion, had a significantly higher proportion of frontal lobe
lesions, and had a significantly lower level of HbA1c.
The patients were assessed within 2 weeks of their
stroke. Multivariate logistic regression analysis revealed
three risk factors for apathy: a history of cerebrovascular
disease, a low HbA1c level and a low MDRS I/P score.
We also compared 12 patients who had post-stroke de-
pression with 63 who did not. The groups were similar
except that a significantly higher proportion of patients
with depression had temporal lobe lesions.
Our results differed from those of previous studies
that had attempted to identify risk factors for post-
stroke apathy. Sagen et al. [17] assessed patients within
the first 2 weeks and at 4 months after the stroke, and,
using multivariate logistic regression analysis, found that
at 4 months after the stroke, somatic comorbidity was
significantly associated with apathy and there was a bor-
derline association with an HADS-D score ≥8 at admis-
sion. Caeiro et al. [3] assessed patients during the acute
phase of a stroke (≤ 4 days) and stepwise regression ana-
lysis showed that cerebral hemorrhage, a low level of
education and a right hemispheric lesion were predic-
tors. Brodaty et al. [4] assessed patients at 3–6 months
after a stroke and performed univariate analysis which
showed that older age, more functional dependency and
Table 6 Determinants of significant risk factors
associated with post-stroke depression (n = 75)
(Continued)
Stroop color-naming
B-Atime 1.01 (0.99, 1.02) 0.409
B-Anumber 0.97 (0.90, 1.05) 0.457
*Significant factor, P < 0.05.
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL-C
Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein
cholesterol, HbA1c Hemoglobin A1c, NIHSS National Institutes of health stroke
scale, MMSE Mini-mental state examination, MoCA Montreal cognitive
assessment, MDRS I/P Mattis dementia rating scale initiation/preservation
subset, FAB Frontal assessment Battery, HAMD Hamilton depression scale.
Yang et al. BMC Psychiatry 2013, 13:164 Page 7 of 10
http://www.biomedcentral.com/1471-244X/13/164a lower score on the MMSE were associated with apathy.
Mayo et al. [18] assessed apathy in 408 stroke patients
by telephone interviews with caregivers at 1, 3, 6 and
12 months after the stroke and analyzed the data using
the group-based trajectory method; they found that
greater apathy was predicted by older age, poor cognitive
status and low functional status. One possible reason for
the conflicting findings is that assessments were carried
out at different periods after the stroke. In our study, pa-
tients were assessed within 2 weeks of the stroke during
the subacute phase. Different variables were assessed
and different assessment instruments were used.
MDRS I/P
We found that a decrease in the MDRS I/P score was a
risk factor for both post-stroke apathy and post-stroke
depression. Patients with one or both of these scoured
lower than did the control group. Patients with post-
stroke apathy without depression also had lower scores
on the MMSE and the MoCA than did controls; how-
ever, they had lower HAMD scores than those without
apathy but with depression, suggesting that these groups
are really different.
In our study, abnormalities were not found in B-Atime
and B-Anumber. The Stroop Color Word Test can be
used to evaluate the degree of impairment of the lateral
and inner-upper frontal lobe [19], but fails to specifically
assess the impairment of the whole frontal lobe.
The frontal-subcortical circuit has been found to con-
nect the frontal cortex and the striatum, globus pallidus,
substantia nigra and thalamus, and functions as an im-
portant effector mechanism and interacts adaptively
[20,21]. Dysfunction of the frontal-subcortical circuit is
characterized by a reduction in executive function, ap-
athy and impulsive behavior. Studies have revealed that
most stroke patients with depression and executive dys-
function had infarct lesions in the frontal lobe [22,23]. A
study of participants in the Age Gene/Environment
Susceptibility-Reykjavik Study found that infarct lesions
involving both cortex and subcortex were related
to compromised processing and executive function[24]. Another study found that among patients with
frontotemporal dementia, the severity of apathy was as-
sociated with atrophy in the right dorsolateral prefrontal
cortex [25]. Brodaty et al. found that among stroke pa-
tients who underwent MRI there was a trend for apathy
to be associated with the extent of MR signal abnor-
malities (hypertintensities) in the deep white matter
and in the right hemisphere and right frontal-
subcortical circuit [4].
History of cerebrovascular disease
We also found that a history of cerebrovascular disease
was a risk factor for post-stroke apathy. Angelelli et al.
found that apathy was more frequently found at
6 months after a stroke than during the subacute phase
[26]. Following cerebral infarction, the nerve fibers dis-
tant from the lesion may experience secondary damage.
Animal studies have shown that connectivity remodeling
was present in the cortex, hypothalamus, striatum,
hippocampus and tissues surrounding the lesions follow-
ing a stroke [27-30]. We therefore speculate that one
possible explanation for a history of cerebrovascular dis-
ease as a risk factor for post-stroke apathy is that infarcts
and secondary damage to nerve fibers following a stroke
may impair the frontal-subcortical circuit and connectiv-
ity remodeling. Alexopoulos et al. [31] postulated two
broad hypotheses for the mechanism of vascular depres-
sion. The first hypothesis was that small lesions
disrupting critical neural pathways might precipitate vas-
cular depression. The second was that an accumulation
of lesions exceeding a threshold predisposes to depres-
sion. The second hypothesis, which is a “threshold hy-
pothesis,” is most applicable to patients who have
neurologically silent lesions or an old stroke. Hama et al.
[32] investigated the correlation between damage to the
basal ganglia or frontal lobe and depression (both
affective and apathetic dimensions) in a study of 243
stroke patients examined with CT, and suggested that
affective depression was associated with left frontal lobe
damage whereas apathetic depression was associated
with damage to the basal ganglia in both hemispheres.
Our finding that there was a tendency for a larger pro-
portion of patients in the apathy group to have a history
of cerebrovascular disease compared with the non-
apathy group suggests that there was a larger proportion
of recurrent stroke cases in the apathy group compared
with the non-apathy group, and that our finding sup-
ports the threshold hypothesis. Cognitive function was
lower in the apathy group compared with the non-
apathy group. These findings related to a history of
cerebrovascular disease and cognitive function suggest
that repeated ischemic strokes damage brain function
bit by bit, leading to both apathy and cognitive
dysfunction.
Table 7 The results of univariate multinomial logistic regression for determining the risk factors of post-stroke apathy
or depression alone
OR (95% CI)
Without apathy/with depression With apathy/without depression With apathy and depression
(n = 6) (n = 19) (n = 6)
Age (y) 1.04 (0.94, 1.15) 1.12 (1.04, 1.21)* 1.01 (0.91, 1.17)
Gender
Male vs. Female 0.23 (0.04, 1.43) 0.64 (0.21, 1.95) 0.93 (0.15, 5.72)
Education (y) 0.87 (0.61, 1.11) 0.73 (0.61, 0.88)* 1.17 (0.94, 1.46)
Frontal
Yes vs. no 2.25 (0.35, 14.49) 6.19 (1.88, 20.34)* 0.90 (0.09, 8.80)
Temporal
Yes vs. no 10.50 (1.15, 95.91)* 5.60 (0.93, 33.77) 10.05 (1.15, 95.91)*
Parietal
Yes vs. no 2.00 (0.19, 21.62) 0.56 (0.06, 5.33) Not estimable
Occipital
Yes vs. no 2.73 (0.24, 31.56) Not estimable 2.73 (0.24, 31.56)
Basal ganglia
Yes vs. no 2.33 (0.25, 21.89) 1.01 (0.32, 3.22) 2.33 (0.25, 21.89)
Cerebellum
Yes vs. no 10.50 (1.15, 95.91)* 1.67 (0.10, 13.70) Not estimable
Brain stem
Yes vs. no 2.39 (0.42, 13.40) 3.28 (1.07, 10.02)* Not estimable
Corona radiata
Yes vs. no 0.48 (0.08, 2.61) 1.01 (0.32, 3.22) Not estimable
Cerebrovascular disease
Yes vs. no 3.40 (0.59, 19.54) 3.06 (0.98, 9.60) 3.40 (0.59, 19.54)
Hypertension
Yes vs. no 2.33 (0.25, 21.89) 0.64 (0.21, 1.95) 0.47 (0.08, 2.61)
Diabetes mellitus
Yes vs. no Not estimable 0.45(0.11, 1.81) 0.48 (0.05, 4.49)
Smoking
Yes vs. no 0.55 (0.09, 3.31) 1.22 (0.41, 3.57) 1.10 (0.20, 6.03)
Drinking
Yes vs. no Not estimable 1.56 (0.50, 4.88) 0.53 (0.06, 5.05)
SBP (mmHg) 0.99 (0.94, 1.03) 0.98 (0.96, 1.01) 0.98 (0.94, 1.03)
DBP (mmHg) 1.01 (0.97, 1.05) 0.97 (0.93, 1.01) 0.97 (0.90, 1.03)
Heart rate (bpm) 1.01 (0.94, 1.09) 0.99 (0.94, 1.03) 1.01 (0.93, 1.08)
Total cholesterol (mmol/L) 1.58 (0.59, 4.19) 0.68 (0.36, 1.30) 0.95 (0.37, 2.48)
Triglycerides (mmol/L) 0.95 (0.46, 1.95) 0.49 (0.20, 1.18) 0.47 (0.12, 1.90)
LDL-C (mmol/L) 2.72 (0.73, 10.09) 0.79 (0.33, 1.90) 0.73 (0.19, 2.80)
HDL-C (mmol/L) 0.63 (0.03, 12.44) 0.26 (0.03, 2.22) 3.13 (0.22, 45.71)
HbA1c (%) 0.90 (0.54, 1.59) 0.48 (0.21, 1.09) 0.33 (0.08, 1.41)
NIHSS 1.06 (0.71, 1.57) 1.04 (0.82, 1.32) 1.14 (0.80, 1.61)
MMSE score 0.81 (0.63, 1.05) 0.72 (0.59, 0.87)* 0.77 (0.61, 0.98)*
MoCA score 0.85 (0.72, 1.01) 0.82 (0.73, 0.93)* 0.84 (0.71, 0.99)*
MDRS I/P 0.85 (0.71, 1.01) 0.85 (0.75, 0.95)* 0.74 (0.60, 0.92)*
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Table 7 The results of univariate multinomial logistic regression for determining the risk factors of post-stroke apathy
or depression alone (Continued)
FAB 0.87 (0.67, 1.12) 0.81 (0.69, 0.96)* 0.99 (0.73, 1.36)
HAMD 8.01 (1.27, 50.73)* 1.07 (0.82, 1.38) 11.16 (1.68, 74.05)*
Stroop color-naming
B-Atime 1.01 (0.99, 1.03) 1.01 (0.99, 1.02) 1.01 (0.99, 1.03)
B-Anumber 0.95 (0.85, 1.07) 0.93 (0.86, 1.01) 0.94 (0.84, 1.04)
*Significant factor, P < 0.05.
Reference group: Without apathy and depression (n = 44).
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol,
HbA1c Hemoglobin A1c, NIHSS National Institutes of health stroke scale, MMSE Mini-mental state examination, MoCA Montreal cognitive assessment, MDRS I/P
Mattis dementia rating scale initiation/preservation subset, FAB Frontal assessment battery, HAMD Hamilton depression scale.
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We found that the level of HbA1c was also a risk factor
for post-stroke apathy. Padala et al. [33] found that ap-
athy was prevalent in patients with diabetes without de-
pression. The mean HbA1c level was 0.66% lower for
apathetic patients as compared to non-apathetic ones.
Apathy may have a negative impact on self-care behav-
iors and diabetes control [33]. To the best of our know-
ledge, this is the first time that this variable has been
associated with post-stroke apathy. Because of small
sample size, however, it is very likely that the statistically
significant relationship between HbA1c and post-stroke
apathy that we found was due to chance. Therefore, this
possible relationship needs to be explored further in lar-
ger studies before conclusions can be drawn.
Notably, results from our additional logistic regression
analysis on patients separated into four categories, using
patients without apathy and depression as the reference
category, showed that most findings are largely similar;
however, this additional analysis is limited by the lack of
multivariate analysis due to small sample size. In this
limited analysis, HbA1c is not a risk factor for post-
stroke apathy, and new brain areas had also shown sig-
nificant difference such as brain stem for post-stroke ap-
athy and cerebellum for post-stroke depression. Thus,
this highlights the importance of having more studies
with larger sample size in order to confirm our findings.
Limitations
Our study had several limitations. The sample size of 75
stroke patients was small and the study was carried out at
only one medical center with the testing instruments used
being selected based on the availability of department and
hospital team support. Also, there was no further investi-
gation of the influence of damage in the cerebral regions
on apathy or on the influence of impaired connectivity in
each cerebral region on apathy. In addition, we excluded
patients with severe aphasia because they could not
complete the evaluation, and this might limit the
generalization of our findings. Moreover, as pointed out
by Mayo et al. [18], based on modern psychometricstandards, there is no available measurement of apathy
that would be considered optimal. Lastly, we attempted to
identify “risk factors” for apathy or depression alone; how-
ever, results of multivariate multinomial logistic regression
were not estimable due to small sample size.
Conclusions
A history of cerebrovascular disease and a low MDRS I/
P score appeared to be predictors of post-stroke apathy
in the subacute phase. A low MDRS I/P score was also
identified as a predictor of post-stroke depression. Our
results suggested that a low HbA1c level might also be a
predictor of post-stroke apathy but, because of small
sample size, we believe that this finding may be
explained by chance. We speculate that many risk fac-
tors may lead to repeated ischemic stroke events, so that
eventually the accumulation of lesions exceeds a thresh-
old which then results in apathy as well as depression
and cognitive disorders. These findings may help clini-
cians recognize and treat apathy and depression in pa-
tients after a stroke; however, before our findings
become useful in a clinical setting, they would need to
be confirmed in larger studies.
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